Pharmacogenetic study of methotrexate and 6-mercaptopurine related genes in Korean pediatric patients with acute lymphoblastic leukemia

被引：0
|
作者：
Kang, Hyoung Jin [1 ]
Seo, Young-Jin [1 ]
Lee, Chang Jin [1 ]
Kim, Hyery [1 ]
Jang, Mi Kyung [1 ]
Koh, Sang Hyeok [1 ]
Oh, Yongtaek [2 ]
Han, Byoung-Don [2 ]
Kim, Chul Woo [3 ]
Kim, Eun Kyung [1 ]
Shin, Hee Young [1 ]
Ahn, Hyo Seop [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Pediat, Seoul, South Korea
[2] YeBt Co LTD, Seoul, South Korea
[3] Dept Pathol, Seoul, South Korea
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4195.4195
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4195
引用
收藏
页码：116B / 116B
页数：1
相关论文
共 50 条
  • [41] 6-MERCAPTOPURINE IN COMBINATION CHEMOTHERAPY OF ACUTE LEUKEMIA
    SAMPEY, JR
    INTERNATIONAL RECORD OF MEDICINE, 1961, 174 (05): : 297 - &
  • [42] INDUCTION OF REMISSION IN ACUTE LEUKEMIA OF CHILDHOOD BY COMBINATION OF PREDNISONE AND EITHER 6-MERCAPTOPURINE OR METHOTREXATE
    KRIVIT, W
    BRUBAKER, C
    HARTMANN, J
    MURPHY, ML
    PIERCE, M
    THATCHER, G
    JOURNAL OF PEDIATRICS, 1966, 68 (06): : 965 - +
  • [43] Induction of Remission in Acute Leukemia of Childhood by Combination of Prednisone and Either 6-Mercaptopurine or Methotrexate
    Vitanza, Nicholas A.
    JOURNAL OF PEDIATRICS, 2016, 173 : 100 - 100
  • [44] COMBINATION OF 6-MERCAPTOPURINE, VINCRISTINE, METHOTREXATE, AND PREDNISONE IN RESISTANT OR RELAPSED ACUTE NONLYMPHOID LEUKEMIA
    LEONE, G
    PAGANO, L
    MARRA, R
    LANDOLFI, R
    CUDILLO, L
    STORTI, S
    MANGO, G
    ALFANO, G
    DONOFRIO, G
    CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 751 - 753
  • [45] GENETIC-VARIATION IN RESPONSE TO 6-MERCAPTOPURINE FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    LENNARD, L
    LILLEYMAN, JS
    VANLOON, J
    WEINSHILBOUM, RM
    LANCET, 1990, 336 (8709): : 225 - 229
  • [46] The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia
    de Beaumais, T. Adam
    Dervieux, T.
    Fakhoury, M.
    Medard, Y.
    Azougagh, S.
    Zhang, D.
    Yakouben, K.
    Jacqz-Aigrain, E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 653 - 658
  • [47] Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia
    Filhon, B.
    Dumesnil, C.
    Van Dreden, P.
    Schneider, P.
    Vasse, M.
    Vannier, J. P.
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1164 - 1166
  • [48] ALLOPURINOL USE WITH 6-MERCAPTOPURINE IN MAINTENANCE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
    Phillips, Lia
    Minson, Katherine
    Castellino, Sharon
    Bergsagel, John
    Lew, Glen
    Sabnis, Himalee
    Pauly, Melinda
    Keller, Frank
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [49] 6-MERCAPTOPURINE DOSAGE REDUCTION AND TPMT POLYMORPHISMS IN THE TREATMENT OF CHILDREN ACUTE LYMPHOBLASTIC LEUKEMIA
    Ferreira Baptista, A.
    Coucelo, M.
    Garrido, T.
    Mendes, M. J.
    Marini, S.
    Saturnino, H.
    Silva, S.
    Brito, M. J.
    Benedito, M.
    Ribeiro, M. L.
    HAEMATOLOGICA, 2014, 99 : 277 - 277
  • [50] Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia
    Conneely, Shannon E.
    Cooper, Stacy L.
    Rau, Rachel E.
    FRONTIERS IN ONCOLOGY, 2020, 10
12345